Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaccine
Biotech
Moderna scraps congenital virus program after vax fails ph. 3
While the mRNA-1647 vaccine was well-tolerated, Moderna said, the shot’s ability to prevent infection was well below the company’s target.
Darren Incorvaia
Oct 22, 2025 5:15pm
NIH head says public distrust prompted mRNA vaccine rollback
Aug 12, 2025 2:08pm
Sanofi inks $1.15B buyout to boost RSV pipeline
Jul 22, 2025 4:20am
Fierce Healthcare
RFK Jr. defends proposed HHS budget as Dems slam cuts
Jun 24, 2025 6:00pm
GSK offloads shigella vaccine to Bharat ahead of phase 3
Jun 12, 2025 9:18am
Arcturus doubles down on mRNA, axes several early-stage assets
May 13, 2025 1:32pm